Last reviewed · How we verify
NCT07509775
Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis (AS): A Cohort Study Protocol Focusing on Spondyloarthritis Research Consortium of Canada (SPARCC) Scoring System
trial in Ankylosing Spondylitis (AS) in 210 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | China-Japan Friendship Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 210 |
| Start date | 19 January 2026 |
| Primary completion | 31 December 2027 |
| Estimated completion | 30 June 2028 |
| Sites | 1 location across China |
Conditions studied
- Ankylosing Spondylitis (AS) — all drugs for Ankylosing Spondylitis (AS) →
Sponsor
China-Japan Friendship Hospital
Who can join
Adults 18 to 75, any sex, with Ankylosing Spondylitis (AS). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to evaluate the long-term effects of Integrated Medicine on radiographic progression in patients diagnosed with Ankylosing spondylitis (AS).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07509775
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ankylosing Spondylitis (AS)
Currently open trials in the same condition.
- NCT07262294 — Deep Breathing Combined With Core Stability Exercises in the Treatment of Patients With Ankylosing Spondylitis · NA · recruiting
- NCT06707194 — Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis · Phase 4 · recruiting
- NCT06988813 — Bidirectional Cohort Study of Nanfang Spondyloarthritis · recruiting
- NCT06844643 — The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study · recruiting
- NCT05303285 — A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis · Phase 4 · recruiting
Other China-Japan Friendship Hospital trials
Trials by the same sponsor.
- NCT07482995 — Effects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults · NA · not yet recruiting
- NCT07406932 — A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial L · NA · not yet recruiting
- NCT07339956 — Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic Agents · EARLY_PHASE1 · not yet recruiting
- NCT07280429 — ICIAM Rehabilitation Program Study: A Randomized Controlled Trial · NA · not yet recruiting
- NCT07135206 — Risk of Acute Kidney Injury in Pulmonary Endarterectomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07509775 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by China-Japan Friendship Hospital
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07509775.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing